Rapid Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Urine Samples via an Asymmetric Polymerase Chain Reaction-Cas12a Platform
Analytical Chemistry · 09.12.2025 · 97 (48) · 26466-26474
DOI: 10.1021/acs.analchem.5c04410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 19.11.2025. Verfasst von Laibao Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life…. Hauptthemen laut MEDLINE: Bacteria, Anti-Bacterial Agents, Polymerase Chain Reaction, CRISPR-Associated Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Key Discipline of Zhejiang Province in Medical Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Antimicrobial resistance poses a critical global health challenge, largely due to the prolonged turnaround times of conventional pathogen identification (ID) and antimicrobial susceptibility testing (AST). Here, we present a clinically validated diagnostic platform integrating asymmetric polymerase chain reaction (aPCR) with CRISPR/Cas12a for direct bacterial ID and phenotypic AST from urine samples. Unlike traditional multiplex PCR requiring complex primer sets, our platform employs a singleplex aPCR targeting the V3-V4 region of 16S rDNA to generate single-stranded and double-stranded DNA. This design enables protospacer adjacent motif-free activation of Cas12a when required via the ssDNA fraction generated by aPCR, facilitating species-level multiplex detection of six common uropathogens at 103 CFU/mL via programmable CRISPR/Cas12a crRNAs. Phenotypic AST is accomplished within 60 min by quantifying nucleic acid changes following antibiotic exposure, allowing accurate discrimination between susceptible and resistant strains. When validated with 86 clinical urine samples, the aPCR-Cas12a platform achieved complete concordance with culture-based identification among the 45 samples carrying target pathogens and demonstrated high accuracy for AST, confirming its reliability for direct pathogen detection and susceptibility assessment from urine. The complete workflow requires only 5.5 h, significantly reducing the diagnostic time compared to standard methods (>48 h). This rapid, cost-effective, and scalable platform offers a promising solution for infection diagnosis and antimicrobial stewardship, with strong potential for integration into routine clinical microbiology and point-of-care settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
- Affiliated Yueqing Hospital, Wenzhou Medical University, Yueqing, Zhejiang 325600, China.
ORCID-Profile: Laibao Zheng
Förderung
- Key Discipline of Zhejiang Province in Medical Technology
- National Natural Science Foundation of China
Zitieren
APA
Zheng, L., Zhou, X., Zhang, Y., Wang, W., Chen, C., Lin, X., Zheng, Y., & Lou, Y. (2025). Rapid Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Urine Samples via an Asymmetric Polymerase Chain Reaction-Cas12a Platform. Analytical Chemistry, 97(48), 26466-26474. https://doi.org/10.1021/acs.analchem.5c04410
Vancouver
Zheng L, Zhou X, Zhang Y, Wang W, Chen C, Lin X, et al. Rapid Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Urine Samples via an Asymmetric Polymerase Chain Reaction-Cas12a Platform. Analytical Chemistry. 2025;97(48):26466-26474. doi:10.1021/acs.analchem.5c04410
BibTeX
@article{Zheng2025,
author = {Zheng, Laibao and Zhou, Xinxi and Zhang, Yan and Wang, Weiwei and Chen, ChenLu and Lin, Xuefeng and Zheng, Yan and Lou, Yongliang},
title = {Rapid Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Urine Samples via an Asymmetric Polymerase Chain Reaction-Cas12a Platform},
journal = {Analytical Chemistry},
year = {2025},
volume = {97},
number = {48},
pages = {26466--26474},
doi = {10.1021/acs.analchem.5c04410}
}
EUVIMED